It is important to note that while the association of CCL2 upregulation in CRS type 4 models has not been addressed to date, its role in cardiovascular diseases suggests that it may represent a potential risk factor for developing CRS type 4. This evidence concerns the gene CCL2 and cardiovascular disorder.